Europe Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cancer Gene Therapy Market, by Therapy
1.4.2 Europe Cancer Gene Therapy Market, by End User
1.4.3 Europe Cancer Gene Therapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Cancer Gene Therapy Market by Therapy
3.1 Europe Gene Induced Immunotherapy Market by Country
3.2 Europe Oncolytic Virotherapy Market by Country
3.3 Europe Gene Transfer Market by Country

Chapter 4. Europe Cancer Gene Therapy Market by End User
4.1 Europe Hospitals Market by Country
4.2 Europe Diagnostic centers Market by Country
4.3 Europe Research Institutes Market by Country

Chapter 5. Europe Cancer Gene Therapy Market by Country
5.1 Germany Cancer Gene Therapy Market
5.1.1 Germany Cancer Gene Therapy Market by Therapy
5.1.2 Germany Cancer Gene Therapy Market by End User
5.2 UK Cancer Gene Therapy Market
5.2.1 UK Cancer Gene Therapy Market by Therapy
5.2.2 UK Cancer Gene Therapy Market by End User
5.3 France Cancer Gene Therapy Market
5.3.1 France Cancer Gene Therapy Market by Therapy
5.3.2 France Cancer Gene Therapy Market by End User
5.4 Russia Cancer Gene Therapy Market
5.4.1 Russia Cancer Gene Therapy Market by Therapy
5.4.2 Russia Cancer Gene Therapy Market by End User
5.5 Spain Cancer Gene Therapy Market
5.5.1 Spain Cancer Gene Therapy Market by Therapy
5.5.2 Spain Cancer Gene Therapy Market by End User
5.6 Italy Cancer Gene Therapy Market
5.6.1 Italy Cancer Gene Therapy Market by Therapy
5.6.2 Italy Cancer Gene Therapy Market by End User
5.7 Rest of Europe Cancer Gene Therapy Market
5.7.1 Rest of Europe Cancer Gene Therapy Market by Therapy
5.7.2 Rest of Europe Cancer Gene Therapy Market by End User

Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 GlaxoSmithKline PLC (GSK)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Amgen, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Bristol Myers Squibb Company
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Karyopharm Therapeutics, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expense
6.6 Gilead Sciences, Inc.
6.6.1 Company overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expenses
6.7 Adaptimmune Limited
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Genelux Corporation
6.8.1 Company Overview
6.9 Sarepta Therapeutics, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Research & Development Expenses